FEATURED PROGRAM

Out of Stem Cells:
The Growth of Entrepreneurial Opportunity

Saturday, March 18, 2006

at California Institute of Technology
Pasadena, California
Registration and Continental Breakfast:
8:00AM Baxter Hall
Program: 9:00 a.m. to 11:00 a.m. at Baxter Lecture Hall
Networking: 11:00 a.m. to 12:00 p.m. at Baxter Lecture Hall
Cost: $40 ($10 for students with full-time student ID;
free to Caltech students)

The hottest field in biotech research and development today involves stem cells. Headlines appear almost daily. Promoters make exorbitant claims, some researchers commit elaborate frauds, and state and federal governments commit billions of dollars to research. Venture capital firms seek out sound ventures. Angels look for the right scientists to back. Pharmaceutical companies want to invest. Some stem cell research ignites political and cultural conflicts.

Why? Because stem cell research is enormously important. Many private fortunes will be made, and many investors’s dollars will be lost. Many entrepreneurs and small firms will be very successful while others will fail. Some firms have already produced highly successful products, while others are still trying.

The field is open to resourceful entrepreneurs, and to scientists who build the right team to manage and commercialize stem cell technology.

Our March 18, 2006, Caltech/MIT Enterprise Forum program will explore the fascinating and inviting world of stem cell research and development for entrepreneurs and middle market companies. The theme of the program is the state of stem cell research in Southern California, and its near term prospects for entrepreneurs.

The program will address the following issues:

I. What are the unique properties of all stem cells that are of interest to entrepreneurs and the
   large biotech companies?
II. Why hasn't embryonic stem cell research attracted more private capital?
III. Why does adult stem cell research have a much brighter real-term future?
IV. What are the potential uses of human stem cells, and the commercial and technical obstacles
    that must be overcome before these potential uses will be realized?

Our panel members will explore entrepreneurial opportunities in this field. They will highlight companies that are achieving traction and success in this area. They will explore the relationship between stem cell R&D by entrepreneurs and middle market companies, and large pharmaceutical or other health care enterprises. They will describe the sources of funding currently available, from government grants to venture capital investments, from strategic partnerships to angel funding.

Don’t miss this timely and informative meeting!

RESEARCH PRESENTER:

Dr. John S. Yu
Co-Director of the Comprehensive Brain Tumor Program
Maxine Dunitz Neurosurgical Institute
Cedars-Sinai Medical Center

CASE PRESENTATION

Dr. Robert Chow
Vice Chairman and Founder,
Global Medical Director
StemCyte, Inc.
http://www.stemcyteinc.com/

CASE PRESENTATION

Larry A. May
Executive
Phase 3 Medical Neostem
www.phase3med.com

MODERATOR & PRODUCER

Russ Frandsen
Attorney at Law
Reed Smith LLP

PROGRAM SPONSOR

FOUNDING SPONSORS

	Caltech Industrial Relations Center
	Caltech Alumni Association
	MIT Alumni Association

The Caltech/MIT Enterprise Forum is administered in
conjunction with Pasadena Entretec